July 20, 2017
Accenture Completes Acquisition of LabAnswer, Expands Ability to Improve the Discovery of New Products through Accenture Scientific Laboratory Informatics
 
NEW YORK; July 20, 2017 – In a move to provide organizations with more comprehensive scientific informatics capabilities, Accenture (NYSE: ACN) has completed its acquisition of LabAnswer, a leading U.S.-based research and laboratory informatics technology consulting firm.
 
The acquisition, which was first announced on June 1, 2017, enhances Accenture’s ability to apply digital technologies to revolutionize scientific and laboratory processes across a variety of industries and spanning the entire product lifecycle. It also coincides with the launch of Accenture Scientific Informatics Services, which combines LabAnswer’s scientific and laboratory informatics expertise with Accenture’s strategic and business consulting capabilities, industry platforms, innovation approach and global scale.
 
Leveraging digital technologies such as automation, artificial intelligence, Internet of Things, analytics and cloud, in combination with a fundamental redesign of the scientific user experience, Accenture Scientific Informatics Services helps organizations better capture, manage, integrate and analyze complex scientific data. This can improve the discovery and manufacturing of new products, improve quality, ensure compliance, reduce time to market and improve operational efficiency.
 
Completing the acquisition of LabAnswer dramatically increases the breadth of our R&D and manufacturing capabilities and enables us to be a leading provider of scientific and laboratory consulting and technology services to a variety of innovation-based industries and government agencies,” said Brad Michel, a managing director in Accenture’s Life Sciences practice and lead for Accenture Scientific Informatics Services. “We are very excited to welcome the LabAnswer team to Accenture. Together, we will help our clients innovate and transform their operations by streamlining scientific processes from early stage research through development and onto manufacturing and quality control, with the ability to partner from the earliest stages of strategic planning through to implementation and support.”
 
Founded in 1990 with approximately 250 employees, LabAnswer is a privately-held and a leading laboratory informatics consultancy specialized in providing independent insights for the design, build, deployment, externalization and ongoing support of enterprise scientific data solutions. Headquartered in Sugar Land, TX, it serves clients in several industries in addition to life sciences, including consumer goods, resources, chemicals, energy and government. LabAnswer provides services to support scientific and laboratory functions in the research, quality and manufacturing functions of organizations in these industries.
 
About Accenture
Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions – underpinned by the world’s largest delivery network – Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With more than 411,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at www.accenture.com.
  
Forward-Looking Statements
Except for the historical information and discussions contained herein, statements in this news release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “should,” “likely,” “anticipates,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” “positioned,” “outlook” and similar expressions are used to identify these forward-looking statements. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied. These include, without limitation, risks that: the transaction might not achieve the anticipated benefits for Accenture; Accenture’s results of operations could be adversely affected by volatile, negative or uncertain economic conditions and the effects of these conditions on the company’s clients’ businesses and levels of business activity; Accenture’s business depends on generating and maintaining ongoing, profitable client demand for the company’s services and solutions including through the adaptation and expansion of its services and solutions in response to ongoing changes in technology and offerings, and a significant reduction in such demand or an inability to respond to the changing technological environment could materially affect the company’s results of operations; if Accenture is unable to keep its supply of skills and resources in balance with client demand around the world and attract and retain professionals with strong leadership skills, the company’s business, the utilization rate of the company’s professionals and the company’s results of operations may be materially adversely affected; the markets in which Accenture competes are highly competitive, and Accenture might not be able to compete effectively; Accenture could have liability or Accenture’s reputation could be damaged if the company fails to protect client and/or company data from security breaches or cyberattacks; Accenture’s profitability could materially suffer if the company is unable to obtain favorable pricing for its services and solutions, if the company is unable to remain competitive, if its cost-management strategies are unsuccessful or if it experiences delivery inefficiencies; changes in Accenture’s level of taxes, as well as audits, investigations and tax proceedings, or changes in tax laws or in their interpretation or enforcement, could have a material adverse effect on the company’s effective tax rate, results of operations, cash flows and financial condition; Accenture’s results of operations could be materially adversely affected by fluctuations in foreign currency exchange rates; Accenture’s business could be materially adversely affected if the company incurs legal liability; Accenture’s work with government clients exposes the company to additional risks inherent in the government contracting environment; Accenture might not be successful at identifying, acquiring, investing in or integrating businesses, entering into joint ventures or divesting businesses; Accenture’s Global Delivery Network is increasingly concentrated in India and the Philippines, which may expose it to operational risks; as a result of Accenture’s geographically diverse operations and its growth strategy to continue geographic expansion, the company is more susceptible to certain risks; adverse changes to Accenture’s relationships with key alliance partners or in the business of its key alliance partners could adversely affect the company’s results of operations; Accenture’s services or solutions could infringe upon the intellectual property rights of others or the company might lose its ability to utilize the intellectual property of others; if Accenture is unable to protect its intellectual property rights from unauthorized use or infringement by third parties, its business could be adversely affected; Accenture’s ability to attract and retain business and employees may depend on its reputation in the marketplace; if Accenture is unable to manage the organizational challenges associated with its size, the company might be unable to achieve its business objectives; any changes to the estimates and assumptions that Accenture makes in connection with the preparation of its consolidated financial statements could adversely affect its financial results; many of Accenture’s contracts include payments that link some of its fees to the attainment of performance or business targets and/or require the company to meet specific service levels, which could increase the variability of the company’s revenues and impact its margins; Accenture’s results of operations and share price could be adversely affected if it is unable to maintain effective internal controls; Accenture may be subject to criticism and negative publicity related to its incorporation in Ireland; as well as the risks, uncertainties and other factors discussed under the “Risk Factors” heading in Accenture plc’s most recent annual report on Form 10-K and other documents filed with or furnished to the Securities and Exchange Commission. Statements in this news release speak only as of the date they were made, and Accenture undertakes no duty to update any forward-looking statements made in this news release or to conform such statements to actual results or changes in Accenture’s expectations.
 
# # #
 
 
Contact:
 
Cam Granstra
Accenture
+ 1 312 693 5992
cameria.l.granstra@accenture.com